In August 2021, GQ Labs formally passed the on-site assessment by the China National Accreditation Service for Conformity Assessment (CNAS) and obtained the Laboratory Accreditation Certificate, Certificate No.: CNAS L15279. Subsequently, we successfully passed the surveillance assessment in August 2022, as well as the reassessment in August 2023 and August 2025 respectively. This is a high affirmation of GQ Labs Laboratory's technical level and testing capabilities in the field of clinical biological sample analysis. From 2019 to the present, our company has participated in proficiency testing activities organized by the National Center for Clinical Laboratories/National Institutes for Food and Drug Control annually, passing with full scores each time. The above marks that GQ Labs' clinical biological sample analysis capabilities have reached nationally and internationally recognized management levels and testing capabilities, providing stronger technical support for related services and safeguarding drug research and development.